SCHEMBL10072115

SCHEMBL10072115

O=C(CO)COC/C=C/c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.49
PAM P19021 1/20 0.49
MMP1 P03956 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
MMP12 P39900 1/20 0.43
MAOB P27338 1/20 0.41
LMNA P02545 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
HTR2A P28223 3/20 0.40
HTR2C P28335 3/20 0.40
HTR2B P41595 3/20 0.40
SIGMAR1 Q99720 3/20 0.40
HDAC3 O15379 1/20 0.40
TNKS O95271 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HCAR2 Q8TDS4 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15315162 0.85 IDO1 (0.47) IDO1PAMMMP1MMP2MMP9
SCHEMBL10510400 0.84 PAM (0.58) IDO1PAMMMP1MMP2MMP9
SCHEMBL9857863 0.84 PAM (0.58) IDO1PAMMMP1MMP2MMP9
SCHEMBL18444843 0.84 IDO1 (0.46) IDO1PAMMMP1MMP2MMP9
SCHEMBL7366215 0.81 IDO1 (0.47) IDO1PAMMMP1MMP2MMP9
SCHEMBL7366213 0.81 IDO1 (0.47) IDO1PAMMMP1MMP2MMP9
SCHEMBL10509109 0.81 IDO1 (0.55) IDO1PAMMMP1MMP2MMP9
SCHEMBL9857835 0.81 IDO1 (0.55) IDO1PAMMMP1MMP2MMP9
SCHEMBL22064200 0.79 NPC1 (0.47) IDO1LMNAMEN1KMT2AALDH1A1
SCHEMBL9857423 0.79 IDO1 (0.47) IDO1PAMMMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017021384-A1 ETHYNYL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2017-02-09 WO disclosed
US-20130272978-A1 DIHYDROXYACETONE MONOETHERS MERCK PATENT GMBH (DE) 2013-10-17 US disclosed
WO-2012084121-A1 DIHYDROXYACETONE MONOETHER MERCK PATENT GMBH (DE) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130272978-A1 DIHYDROXYACETONE MONOETHERS GNPAT, UGT1A7, UGT1A3 IDO1 1295/4885PAM 907/4885MMP1 2104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.